Sclerosis News and Research

RSS

Celebrity chef, registered dietitian team up to create nutrition program for people with MS

Amanda Freitag, celebrity chef and recurring judge on the Food Network's "Chopped," and Julie Barto, a registered dietitian specializing in multiple sclerosis, have teamed up to create a nutrition program especially for people with MS.

17 Dec 2010

New study contradicts presence of oxysterols in multiple sclerosis patients

New research findings appearing in the January Journal of Lipid Research indicate that compounds called oxysterols are not present in any significant amount in multiple sclerosis patients, contradicting a previous study that suggested that some of these cholesterol metabolites were associated with MS and could be used as diagnostic tools in the clinic.

16 Dec 2010

SBUMC to rename and dedicate ALS clinic as Christopher Pendergast ALS Center of Excellence

For Chris Pendergast, every Christmas he has been alive to celebrate with his family for the past 17 years has been a gift unto itself. Indeed, in 1993 the then 44-year-old elementary school teacher from Miller Place on Long Island was diagnosed with amyotrophic lateral sclerosis - ALS - the always fatal degenerative neuromuscular disease commonly known as Lou Gehrig's Disease. He was told that he had, at best, three to five years to live.

15 Dec 2010

Survey reveals 40% of consumers prefer to purchase vision care services during weekends, evenings

An independent, national survey reveals 40 percent of consumers prefer to shop for and purchase vision correction services during evenings or weekends.

15 Dec 2010

BRIC researchers discover new protein that improves immune system

Researchers at BRIC, the University of Copenhagen, have discovered for the first time a protein normally found in the body that can act to prevent chronic tissue inflammation.

15 Dec 2010

CGEN-15001 administration shows dramatic therapeutic potential in CIA animal model

Compugen Ltd. announced today that administration of CGEN-15001 in an animal model of rheumatoid arthritis dramatically ameliorates the clinical symptoms of the disease.

15 Dec 2010

Preliminary results from Phase 1b/2a trial of MediciNova's ibudilast in opioid addicts announced

Drug addiction investigators with joint appointments at Columbia University Medical Center and the New York State Psychiatric Institute along with MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Jasdaq Market of the Osaka Securities Exchange, today reported preliminary results of the company's neurological drug candidate, ibudilast (MN-166/AV411), in a Phase 1b/2a trial in opioid addicts. The study was largely funded by the National Institute on Drug Abuse (NIDA) with MediciNova supplementation.

14 Dec 2010

$Indian study confirms vitamin D deficiency as risk factor for hip fracture$

Indian study confirms vitamin D deficiency as risk factor for hip fracture

A study from New Delhi India has revealed high rates of vitamin D deficiency among hip fracture patients, confirming the conclusions of similar international studies which point to vitamin D deficiency as a risk factor for hip fracture.

13 Dec 2010

Physiotherapy Associates announces new MS Specialty Program

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announced its new MS Specialty Program, which includes physical therapy services and a health and wellness program designed to reduce or alleviate the symptoms of MS for patients, available in its more than 600 clinics throughout the United States.

10 Dec 2010

VCP gene causes some instances of familial ALS: Researchers

Using a new gene sequencing method, a team of researchers led by scientists from Johns Hopkins and the National Institutes of Health has discovered a gene that appears to cause some instances of familial amyotrophic lateral sclerosis. The finding could lead to novel ways to treat the more common form of this fatal neurodegenerative disease, which kills the vast majority of the nearly 6,000 Americans diagnosed with ALS every year.

10 Dec 2010

Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.

9 Dec 2010

New technique may help develop novel treatments for brain diseases

Scientists have created a way to isolate neural stem cells - cells that give rise to all the cell types of the brain - from human brain tissue with unprecedented precision, an important step toward developing new treatments for conditions of the nervous system, like Parkinson's and Huntington's diseases and spinal cord injury.

8 Dec 2010

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.

6 Dec 2010

Study: Research findings may help identify drugs to encourage myelin repair in MS patients

Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system, a study has shown.

6 Dec 2010

Multiple sclerosis therapy breakthrough with stem cells

There seems to a glimmer of hope for tens of thousands of multiple sclerosis sufferers as researchers discover a way to repair damaged nerves with stem cells. The British team says their findings could lead to the development of drugs that repair nerves in the brain and spinal cord and potentially reverse some of the symptoms of MS.

5 Dec 2010

Appropriate level of Static Magnetic Field exposure for wound patients needs to be considered

The interest in the biological effects of non-ionizing Electro Magnetic Fields (EMFs) and Static Magnetic Fields (SMFs) on the whole organism, as well on cellular systems, has noticeably increased in recent years in consideration of their increased production (from the generation and transmission of electricity, to domestic appliances and industrial equipment, to telecommunications and broadcasting) and the possible health risk for humans.

4 Dec 2010

UMDNJ experts to discuss IOM guidelines on vitamin D

For media covering the new Institute of Medicine (IOM) guidelines on vitamin D, several experts at the University of Medicine and Dentistry of New Jersey (UMDNJ) are available for comment. The new guidelines updated the dietary reference intakes (DRIs) that the IOM established more than a decade ago and represent a significant change from previous limits.

2 Dec 2010

AMT, Amgen amend GDNF gene license agreement

Amsterdam Molecular Therapeutics Holding N.V., a leader in the development of gene-based therapies, today announced that it has amended and restated its licensing agreement with Amgen for gene therapy applications incorporating the GDNF (glial cell derived neurotrophic factor) gene, to which Amgen holds rights. Financial terms were not disclosed.

2 Dec 2010

Current Opinion in Lipidology journal publishes data on VB-201 for immune-mediated disorders

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of a new concept in the Current Opinion in Lipidology evaluating oxidized phospholipid analogs as potential treatments for chronic inflammatory diseases.

2 Dec 2010

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

Nearly three-quarters of patients with Parkinson's disease experience fatigue or excessive daytime sleepiness (EDS), but clinicians should assess both problems separately in order to improve the profession's understanding of their distinct, but overlapping, physiology. That is the key finding of a study published in the December issue of the European Journal of Neurology.

1 Dec 2010

Sclerosis News and Research

Celebrity chef, registered dietitian team up to create nutrition program for people with MS

New study contradicts presence of oxysterols in multiple sclerosis patients

SBUMC to rename and dedicate ALS clinic as Christopher Pendergast ALS Center of Excellence

Survey reveals 40% of consumers prefer to purchase vision care services during weekends, evenings

BRIC researchers discover new protein that improves immune system

CGEN-15001 administration shows dramatic therapeutic potential in CIA animal model

Preliminary results from Phase 1b/2a trial of MediciNova's ibudilast in opioid addicts announced

Indian study confirms vitamin D deficiency as risk factor for hip fracture

Physiotherapy Associates announces new MS Specialty Program

VCP gene causes some instances of familial ALS: Researchers

Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis

New technique may help develop novel treatments for brain diseases

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

Study: Research findings may help identify drugs to encourage myelin repair in MS patients

Multiple sclerosis therapy breakthrough with stem cells

Appropriate level of Static Magnetic Field exposure for wound patients needs to be considered

UMDNJ experts to discuss IOM guidelines on vitamin D

AMT, Amgen amend GDNF gene license agreement

Current Opinion in Lipidology journal publishes data on VB-201 for immune-mediated disorders

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News